Novartis announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise. Novartis CEO Vasant Narasimham speaks with Bloomberg's Scarlet Fu on the impact of pharma tariffs.

Bank of America CEO Brian Moynihan Talks Credit Card Cap
15:03

BlackRock CEO Larry Fink Talks AI Bubbles
12:04

US Commerce Secretary Howard Lutnick Talks Trump Tariffs, Trade Relations, China
15:27